UCSF’s Clinical and Translational Science Institute is helping UCSF investigators connect with other experts in fields ranging from global health and biostatistics to study design, regulatory knowledge and participant recruitment.
August 08, 2012
March 27, 2012
The UCSF community is invited to hear Allan Basbaum's lecture, “The Neurological Basis of Pain and Its Control,” on April 17 as part of the Second Annual Faculty Research Lecture in Translational Science.
March 12, 2012
UCSF's Clinical and Translational Science Instiute has expanded its board of directors to focus on accountability and to reflect the interests of the broader University community.
December 22, 2011
In a commentary published in the November issue of Academic Medicine, top recruitment experts at UCSF urge academic medical researchers to embrace new methods for recruiting participants into clinical trials.
December 13, 2011
UCSF Chancellor Susan Desmond-Hellmann, MD, former president for product development at Genentech, is featured in a video interview for BioCentury Publications Inc., a major biopharmaceutical news media source, which first aired online on Dec. 11.
November 22, 2011
Although the vast majority of Americans understand the importance of taking part in clinical research to advance medical science, three in four adults have little to no knowledge about how clinical research works or how to participate. UCSF is trying to bridge that information gap.
November 18, 2011
A National Academy of Sciences committee co-chaired by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, recommends the creation of a Google maps-like data network that could transform the future of medical discovery, diagnosis and treatment.
October 27, 2011
UCSF will celebrate “Clinical Research Education Day’’ as the host of Aware for All – San Francisco, a free health education program that is open to the public and designed to help people make informed decisions about participating in clinical research.
October 26, 2011
An 11-month-old partnership between UCSF and Pfizer, Inc., aimed at rapidly moving new therapies into human clinical trials, has selected its first projects for funding and joint development.
October 04, 2011
UCSF Chancellor Susan Desmond-Hellmann on Tuesday outlined a new vision for UCSF — to be the world's preeminent health sciences innovator — as part of a three-year plan.